Medical Daily (12/13, Dovey) reports researchers have identified “biomarkers in four specific subtypes of depression by using functional magnetic resonance imaging (fMRI) brain scans of 1,000 patients with clinical depression, and comparing them to healthy control subjects.” The findings were published online Dec. 5 in Nature Medicine.

Related Links:

— “4 Depression Types: Biomarkers May Help Diagnose Disorder Subtypes, Help Patients Get Better Treatment,”Dana Dovey, Medical Daily, December 13, 2016.

President Obama’s signing of the 21st Century Cures Act was noted on one major network newscast, and received very favorable – though sparse – print coverage highlighting the measure’s potential to save lives and the bipartisan cooperation that brought it into being. NBC Nightly News (12/13, story 8, 1:35, Alexander), for example, remarked on the “rare moment of unity” in “a city badly polarized by politics,” in which Obama, in “what’s likely the last bill-signing of this presidency,” built “a legacy meant to last.”

The Washington Post (12/13, Eilperin, Johnson) reports the bill “had wide bipartisan support and has been held up as an example of what Congress can accomplish by working together.” It contained “several provisions that the White House has championed, including $1 billion for opioid abuse prevention and $4.8 billion for biomedical research funding.” It was “an emotional bill signing ceremony,” says USA Today (12/13, Korte), for a bill that was “a personal project for” Vice President Biden, who was in attendance and delivered remarks, as “the section of the bill allocating $1.8 billion in cancer research funding was named for his son, Beau, whose death from brain cancer in 2015 inspired what the White House called its ‘Cancer Moonshot.’”

Related Links:

— “Obama, paying tribute to Biden and bipartisanship, signs 21st Century Cures Act Tuesday,”Juliet Eilperin, The Washington Post, December 13, 2016.

The New York Times (12/13, A18, Carey, Subscription Publication) reports, “About one in six American adults reported taking at least one psychiatric” medication, “usually an antidepressant or an anti-anxiety medication, and most had been doing so for a year or more, according to a” research letter published online Dec. 12 in JAMA Internal Medicine. The findings are “based on 2013 government survey data on some 242 million adults.”

According to the CBS News (12/12, Welch) website, the research letter also reveals that “over 80 percent of those taking these medications reported long-term use, which experts say is concerning since some” of these medicines “are recommended for shorter use and carry a number of serious risks.”

TIME (12/12, Sifferlin) points out, “More than 20% of white Americans reported being prescribed psychiatric” medications, “compared to about 9% of Hispanic adults, nearly 10% of black adults and close to 5% of Asian adults,” investigators found.

Related Links:

— “One in 6 American Adults Say They Have Taken Psychiatric Drugs, Report Says,”Benedict Carey, The New York Times, December 13, 2016.

HealthDay (12/12, Norton) reports men who played high school football during the 1950’s and 1960’s are not more likely to suffer from dementia or memory problems compared to men who played other sports, according to a small study published in Mayo Clinic Proceedings. Senior researcher Dr. Rodolfo Savica at the Mayo Clinic said, “What we can say is, for that era, football did not increase the risks of neurodegenerative disease compared with other sports.” Researchers reviewed the medical records of almost 300 men who had played football during the time period and almost 200 men who had played other sports during the same period.

Related Links:

— “Was Football Safer Back in the Day?,”Amy Norton, HealthDay, December 12, 2016.

ABC World News Tonight (12/12, Story 10, 0:20, Muir) reported, “A new study shows that high use of…statins” may be associated with “a lower risk of Alzheimer’s for patients over the age of 65.”

CNN (12/12, Howard) reports that the research, published online Dec. 12 in JAMA Neurology, “involved Medicare data on 399,979 statin users.” Investigators “found that those who were exposed to higher levels of statins…were 10% less likely to have an Alzheimer’s disease diagnosis in each of the subsequent five years than those with lower statin exposure.”

HealthDay (12/12) reports that researchers found, however, that “it may depend on the specific statin, and the gender and race or ethnicity of the person taking it.” For instance, “black men appeared to gain no benefit from taking any statin, while white women may lower their risk regardless of which statin they take, the researchers said.”

Related Links:

— “Are statins a key to preventing Alzheimer’s disease?,”Jacqueline Howard, CNN, December 12, 2016.